Menu
Back to User profile » Professor Giuseppe Derosa
Papers published by Professor Giuseppe Derosa:
Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial
Di Pierro F, Iqtadar S, Khan A, Ullah Mumtaz S, Masud Chaudhry M, Bertuccioli A, Derosa G, Maffioli P, Togni S, Riva A, Allegrini P, Khan S
International Journal of General Medicine 2021, 14:2807-2816
Published Date: 24 June 2021
Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study
Di Pierro F, Derosa G, Maffioli P, Bertuccioli A, Togni S, Riva A, Allegrini P, Khan A, Khan S, Khan BA, Altaf N, Zahid M, Ujjan ID, Nigar R, Khushk MI, Phulpoto M, Lail A, Devrajani BR, Ahmed S
International Journal of General Medicine 2021, 14:2359-2366
Published Date: 8 June 2021
Safety and Efficacy of Alpha Lipoic Acid During 4 Years of Observation: A Retrospective, Clinical Trial in Healthy Subjects in Primary Prevention
Derosa G, D'Angelo A, Preti P, Maffioli P
Drug Design, Development and Therapy 2020, 14:5367-5374
Published Date: 3 December 2020
An Evaluation of a Nutraceutical with Berberine, Curcumin, Inositol, Banaba and Chromium Picolinate in Patients with Fasting Dysglycemia
Derosa G, D'Angelo A, Vanelli A, Maffioli P
Diabetes, Metabolic Syndrome and Obesity 2020, 13:653-661
Published Date: 3 March 2020
Coenzyme q10 liquid supplementation in dyslipidemic subjects with statin-related clinical symptoms: a double-blind, randomized, placebo-controlled study
Derosa G, D'Angelo A, Maffioli P
Drug Design, Development and Therapy 2019, 13:3647-3655
Published Date: 21 October 2019
Ascophyllum Nodosum, Fucus Vesiculosus and chromium picolinate nutraceutical composition can help to treat type 2 diabetic patients
Derosa G, Pascuzzo MD, D'Angelo A, Maffioli P
Diabetes, Metabolic Syndrome and Obesity 2019, 12:1861-1865
Published Date: 18 September 2019
Ertugliflozin: a sodium-glucose cotransporter-2 (SGLT-2) inhibitor for glycemic control in type 2 diabetes
Derosa G, Maffioli P
Therapeutics and Clinical Risk Management 2018, 14:1637-1640
Published Date: 7 September 2018
High-dose atorvastatin versus moderate dose on early vascular protection after ST-elevation myocardial infarction
Gavazzoni M, Gorga E, Derosa G, Maffioli P, Metra M, Raddino R
Drug Design, Development and Therapy 2017, 11:3425-3434
Published Date: 4 December 2017
Effect of a food supplement containing berberine, monacolin K, hydroxytyrosol and coenzyme Q10 on lipid levels: a randomized, double-blind, placebo controlled study
D'Addato S, Scandiani L, Mombelli G, Focanti F, Pelacchi F, Salvatori E, Di Loreto G, Comandini A, Maffioli P, Derosa G
Drug Design, Development and Therapy 2017, 11:1585-1592
Published Date: 23 May 2017
Effects of metformin extended release compared to immediate release formula on glycemic control and glycemic variability in patients with type 2 diabetes
Derosa G, D'Angelo A, Romano D, Maffioli P
Drug Design, Development and Therapy 2017, 11:1481-1488
Published Date: 16 May 2017
A review about biomarkers for the investigation of vascular function and impairment in diabetes mellitus
Derosa G, Maffioli P
Vascular Health and Risk Management 2016, 12:415-419
Published Date: 9 November 2016
Retargeting the management of hypercholesterolemia – focus on evolocumab
Colletti A, Derosa G, Cicero AFG
Therapeutics and Clinical Risk Management 2016, 12:1365-1376
Published Date: 6 September 2016
Optimizing glycemic control: clinical utility of exenatide prolonged release injection
Derosa G, Maffioli P
Research and Reports in Endocrine Disorders 2012, 2:41-51
Published Date: 26 September 2012
Patient considerations and clinical utility of a fixed dose combination of saxagliptin/metformin in the treatment of type 2 diabetes
Derosa G, Maffioli P
Diabetes, Metabolic Syndrome and Obesity 2011, 4:263-271
Published Date: 30 June 2011
Endothelial function, blood pressure control, and risk modification: impact of irbesartan alone or in combination
Giuseppe Derosa, Sibilla AT Salvadeo
Integrated Blood Pressure Control 2010, 3:21-30
Published Date: 19 May 2010
Risk management in the treatment of type 2 diabetes with pioglitazone
Giuseppe Derosa, Sibilla AT Salvadeo
Diabetes, Metabolic Syndrome and Obesity 2009, 2:51-60
Published Date: 1 July 2009
Pioglitazone and metformin fixed-dose combination in type 2 diabetes mellitus: an evidence-based review of its place in therapy
Giuseppe Derosa, Sibilla Anna Teresa Salvadeo
Core Evidence 2007, 2:0-0
Published Date: 15 September 2007